KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) Asset Writedowns and Impairment (2017 - 2025)

Xylem (XYL) has 10 years of Asset Writedowns and Impairment data on record, last reported at $2.0 million in Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment fell 84.62% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $5.0 million, down 75.0%, while the annual FY2025 figure was $8.0 million, 14.29% up from the prior year.
  • Asset Writedowns and Impairment reached $2.0 million in Q2 2025 per XYL's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $14.0 million in Q3 2022 and bottomed at $1.0 million in Q1 2021.
  • Average Asset Writedowns and Impairment over 5 years is $5.4 million, with a median of $2.5 million recorded in 2023.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 92.86% in 2023, then soared 500.0% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $11.0 million in 2021, then plummeted by 90.91% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then skyrocketed by 500.0% to $6.0 million in 2024, then tumbled by 66.67% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $2.0 million in Q2 2025, $3.0 million in Q1 2025, and $6.0 million in Q4 2024.